Nabota is a type A botulinum toxin from Daewoong Pharmaceutical Co., Ltd. The product has been approved by the U.S. Food and Drug Administration. This is the first Korean botulinum toxin to enter the US market. Nabota is a competitor to Botox, as it is a cheaper alternative with no change in the way you handle the toxin.The Nabota series consists of two products։ Nabota 100ui and Nabota 200ui.
Filters (Clear All)